NCT05366257View on ClinicalTrials.gov

Real-world Resource Use and Costs of CAR-T Therapies in Diffuse Large B-cell Lymphoma (DLBCL)

CompletedOBSERVATIONAL
Enrollment

160,602

Participants

Timeline

Start Date

August 17, 2020

Primary Completion Date

May 10, 2021

Study Completion Date

May 10, 2021

Conditions
Diffuse Large B-cell Lymphoma (DLBCL)
Interventions
OTHER

CAR-T

infusion of CAR-T therapy among patients with r/r DLBCL

OTHER

Allo-HSCT cohort

Patients received allogeneic hematopoietic stem cell transplant

Trial Locations (1)

07936-1080

Novartis Investigative Site, East Hanover

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY